$0.75
Price
$73M
Market Cap
—
P/E Ratio
-1.4
Forward P/E
$-0.83
EPS (TTM)
—
Dividend Yield
$90M
Cash
$13M
Total Debt
98M
Shares Out
$0.64
$7.29
52-Week Range
Institutional Ownership of ATYR PHARMA INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for ATYR PHARMA INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2019-Q3 | |||||
| SELL | EXIT | — | — | $3.39 | |
| 2019-Q1 | |||||
| BUY | +131.9% | 3.2M | $2M | $7.14 | |
Insider Trading for ATYR PHARMA INC
6 Months Insider Sentiment
Buy $912K
Sell $0
2
Buys
0
Sells
+912K
Net
0
Grants
Largest
$612K
PAUL
$299K
PAUL
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 09, 2025 | SCHIMMEL PAUL | Director | BUY | 318.0K | $0.94 | $299K |
| Oct 08, 2025 | SCHIMMEL PAUL | Director | BUY | 682.0K | $0.90 | $612K |